Insulet Corporation PODD recently made its Omnipod 5 Automated Insulin Delivery (“AID”) system commercially available in Canada for people with type 1 diabetes (ages two years and above).

Insulet announced today that its board of directors appointed Ashley McEvoy as president and CEO, effective immediately.

The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin ...

Insulin pump maker Insulet announced announced Ashley McEvoy would replace Jim Hollingshead as chief executive.

Ashley McEvoy comes to Insulet having worked at the New Jersey-based healthcare company Johnson & Johnson from 1996 to 2023 ...

Insulet recently launched the Omnipod 5 system in Canada ... Analysts forecast revenue to grow annually by 13.4%, driven by expanding their market share in the type 2 diabetes sector and international ...

McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of ...

Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with ...

During Jim’s tenure, Insulet launched its flagship product, Omnipod 5, which has achieved clear market leadership in type 1 diabetes in the U.S. and Europe, and was the first to market in ...